Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PET-adapted therapy after three cycles of ABVD for all stages of Hodgkin lymphoma: results of the GATLA LH-05 trial.
Pavlovsky A, Fernandez I, Kurgansky N, Prates V, Zoppegno L, Negri P, Milone G, Cerutti I, Zabaljauregui S, Mariano R, Grecco HF, Basquiera AL, Saba S, Rudoy S, Sackmann F, Castano V, Remaggi G, Cabrejo M, Roveri E, Casale MF, Cabane V, Taus R, Venturini C, Sakamoto F, Varela AI, Riddick M, Pavlovsky S; Grupo Argentino de tratamiento de Leucemia Aguda (GATLA), Argentina. Pavlovsky A, et al. Among authors: cerutti i. Br J Haematol. 2019 Jun;185(5):865-873. doi: 10.1111/bjh.15838. Epub 2019 Mar 12. Br J Haematol. 2019. PMID: 30864146 Free article.
Risk-adapted therapy with three or six cycles of doxorubicin/bleomycin/vinblastine/dacarbazine plus involved-field radiation therapy in Hodgkin lymphoma, based on prognosis at diagnosis and early response: results from the GATLA study.
Pavlovsky S, Corrado C, Pavlovsky MA, Prates MV, Zoppegno L, Giunta M, Cerutti I, Palomino E, Pagani F, Lastiri F, Bar D, Bezares RF, Avila G. Pavlovsky S, et al. Among authors: cerutti i. Clin Lymphoma Myeloma Leuk. 2010 Jun;10(3):181-5. doi: 10.3816/CLML.2010.n.028. Clin Lymphoma Myeloma Leuk. 2010. PMID: 20511162 Clinical Trial.
Randomized trial of CVPP for three versus six cycles in favorable-prognosis and CVPP versus AOPE plus radiotherapy in intermediate-prognosis untreated Hodgkin's disease.
Pavlovsky S, Schvartzman E, Lastiri F, Magnasco H, Corrado C, Raslawski E, Cancela ME, Ardaiz MC, Cerutti I, Rosso A, Bruno S, Aranguren PN, Salvarezza A, Donato H, Dibar E, Zirone S. Pavlovsky S, et al. Among authors: cerutti i. J Clin Oncol. 1997 Jul;15(7):2652-8. doi: 10.1200/JCO.1997.15.7.2652. J Clin Oncol. 1997. PMID: 9215837 Clinical Trial.
Multivariate analyses of prognostic factors associated with hematopoietic recovery in autograft patients with different sources of progenitor cells. A GATMO experience. Argintine Group of Bone Marrow Transplant.
Pavlovsky S, Koziner B, Milone G, Lastiri F, Bayo R, Fernández I, Dengra C, Martinez Rolón J, Feldman L, Kusminsky G, Corrado C, Bullorsky E, Milone J, Garcia JJ, Cerutti I, Saporito G, Robinson A, Canepa C. Pavlovsky S, et al. Among authors: cerutti i. Ann Oncol. 1996 Sep;7(7):719-24. doi: 10.1093/oxfordjournals.annonc.a010721. Ann Oncol. 1996. PMID: 8905030 Free article. Clinical Trial.
Autologous stem cell transplantation for patients with chronic myeloid leukemia. The Argentine Group of Bone Marrow Transplantation (GATMO) experience.
Koziner B, Dengra C, Lucero G, Klein G, Cánepa C, Milovic V, Milone G, Robinson A, Cerutti I, Saporito G, Kusminsky G, Milone J, Bordone J, Lastiri F; Argentine Group of Bone Marrow Transplantation. Koziner B, et al. Among authors: cerutti i. Cancer. 2002 Dec 1;95(11):2339-45. doi: 10.1002/cncr.10931. Cancer. 2002. PMID: 12436440 Free article.
Cell processing practices in Argentina: report of a multicenter survey.
Bertinetti C, Milone G, Kohan A, Saporito G, Robinson A, García JJ, Milone J, Cerutti I, Feldman L, Jarchum G, Bordone J, Koziner B. Bertinetti C, et al. Among authors: cerutti i. Cytotherapy. 2001;3(2):127-33. doi: 10.1080/14653240152584695. Cytotherapy. 2001. PMID: 12028835 No abstract available.
Results of treatment with an intensive combination induction regimen containing idarubicin in children with acute myeloblastic leukemia: preliminary report of the Argentine Group for Treatment of Acute Leukemia.
Sackmann-Muriel F, Fernández-Barbieri MA, Santarelli MT, Matus-Ridley M, Rosso A, Negri-Aranguren P, Cerutti I, Gomel M, Kvicala R. Sackmann-Muriel F, et al. Among authors: cerutti i. Semin Oncol. 1993 Dec;20(6 Suppl 8):34-8. Semin Oncol. 1993. PMID: 8290970 Clinical Trial.
50 results